|
Welcome to the fourth issue of PharmaView!
Pharmaceutical
Marketers are facing increasing pressures: increasing competition; squeezed
margins; shrinking budgets; more to do and less time to do it. It’s becoming
difficult to work any harder, and of course it's always better to work smarter.
Therefore we bring you the PharmaView.
PharmaView
is a biweekly educational and informative newsletter for improving readers’ marketing
knowledge and reporting the latest news in the pharma industry. It also provides
great opportunities to exchange ideas, network and be recognized among your
peers in the industry.
Through
PharmaView, you can:
Learn peer’s
experience in pharma marketing
Stay in touch with
what’s happening in pharmaceutical marketing today
Be on the
pioneering edge of pharmaceutical marketing
Have networking /
idea exchange opportunities
About Us
Integrating local
knowledge with international perspective,
Consultech Co. Ltd.
offers its clients and prospects one-lstop solutions with sales
and marketing consultancy, advertising and promotion strategies.
Consultech is an affiliate
company of Omnicom, the world's largest advertising and communications
holding company.
Suboxone (Buprenorphine/Naloxone) Approved In European Union for Treatment of
Opioid Dependence
Schering-Plough Corporation
today announced that the European Commission has granted marketing approval to
SUBOXONE(R) (buprenorphine hydrochloride/naloxone hydrochloride) Sublingual
Tablets for the substitution treatment of opioid dependence, within a framework
of medical, social and psychological treatment. The intention of adding the
naloxone component is to deter intravenous misuse.
Oct. 06, 2006
Merck cervical cancer vaccine approved in Europe
Merck & Co Inc's Gardasil, the first vaccine
to prevent cervical cancer, has been approved for sale in the Europe Union, the
joint venture that will market the product in Europe said on Friday.
Sep 22, 2006
Defining pharma’s marketing future
Pharma’s
marketing paradigm must change, but smart companies can meet the challenges
head on by proactively building the partnerships and embracing the
technologies that will allow them to take charge of their own futures,
Jun.
30, 2006
Lilly crosses borders to achieve marketing ROI
Eli Lilly,
like many other big pharmas, knows it will take more than the status quo to
respond to the many pressures facing today’s pharmaceutical industry. So five
years ago, its European Critical Care group set out to pilot a new business
model with a decidedly different approach to sales and marketing.
May
31, 2006
Just What The Patient Ordered——6
ingredients of successful DTP
With
thorough evaluation of brand and audience, direct-to-patient marketing can
offer far better returns than DTC, says Richard Blocki of Abelson-Taylor.
Apr. 2006
Schwarz Pharma is
to be acquired by UCB
Schwarz Pharma,
a German maker of medications for epilepsy, Parkinson's disease, and bladder
control, on Monday agreed to a friendly 4.4 billion euro ($5.64 billion)
takeover offer from UCB
of Belgium.
Sept 28, 2006
Chugai Pharmaceutical Co., Ltd. (Japan) To Establish An Oncology Unit
Chugai Pharmaceutical Co.,
Ltd. , will establish an Oncology Unit within its Sales Division as of October
1, 2006. The unit's mission will be to gain society's trust as an oncology
partner by providing innovative cancer treatment and comprehensive support to
all those fighting cancer.
Sept 27, 2006
Altana sells drugs unit to Nycomed for 4.5
bln eur
German drugs and
chemicals group Altana will sell its drugs business to Denmark's Nycomed for
around 4.5 billion euros ($5.7 billion), breaking up one of Europe's last
remaining drug-chemical hybrids.
Sep 21, 2006
Please feel free to offer
your opinions and advices about PharmaView in order to better our
services. Should you have any comments, or if you want to unsubscribe from PharmaView, please send us an
email: pharmaview@Consultech.com.cn
. Thank you!
|
